Victoria L. Creamer, EVP and Chief People Officer at Charles River Laboratories (CRL), sold 4,179 shares on Aug. 6, 2026 at $259.16 per share, for proceeds of about $1.08 million. The filing indicates the sale was made in the open market and not under a pre-scheduled 10b5-1 trading plan, meaning it was not automatically timed in advance. Creamer is a senior executive, but her role is centered on leadership and human resources rather than day-to-day financial reporting or revenue generation. That can make her trades less directly tied to near-term business performance than trades by a CFO or CEO. Still, any sizable sale by a top officer is worth noting because it reduces the insider’s personal exposure to the stock. This transaction also occurred alongside other recent insider selling at CRL. Over the last 30 days, Shannon M. Parisotto sold about $1.33 million on Aug. 5, and Michael Gunnar Knell sold about $330,060 on Aug. 6. Multiple executive sales close together can look like a cluster, but insider selling often reflects personal diversification, tax planning, or liquidity needs, so the takeaway is limited without more detail on each insider’s remaining holdings and past trading patterns.